Abstract:BACKGROUND:Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in tumor cells, but when used alone, it is not effective in the treatment of TRAIL-resistant tumors. Some studies have shown that gefitinib interacts with recombinant mutant human TRAIL (rmhTRAIL) to induce high levels of apoptosis in gefitinib-responsive bladder cancer cell lines; however, the molecular mechanisms underlying the anticancer effects are not fully understood. Several reports have shown that the death receptor 5 (DR5) plays an important role in sensitizing cancer cells to apoptosis induced by TRAIL. Therefore, we investigated the effects of the combination of drugs and the expression of the DR5 to analyze the growth of a gefitinib-responsive non-small cell lung cancer cell line PC9, which was treated with rmhTRAIL and gefitinib individually or in combination.METHODS:Human PC9 non-small cell lung cancer cells harboring an epidermal growth factor receptor mutation were used as a model for the identification of the therapeutic effects of gefitinib alone or in combination with rmhTRAIL, and cytotoxicity was assessed by MTT assays. Cell cycle and apoptosis were investigated using flow cytometry. Moreover, the effects of drugs on DR5, BAX, FLIP, and cleaved-caspase3 proteins expressions were analyzed using Western blot analyses. Finally, quantitative polymerase chain reaction analysis was carried out to assess whether rmhTRAIL and gefitinib modulate the expression of genes related to drug activity.RESULTS:Gefitinib and rmhTRAIL synergistically interact to inhibit cell proliferation, and apoptosis assessment demonstrated that associations of drug increased the apoptotic index. rmhTRAIL when used alone downregulated DR5 and upregulated BAX, FLIP, and cleaved-caspase3 proteins expressions. However, results obtained in Western blot analyses demonstrated that the combined treatment-induced cell apoptosis was achieved involving upregulated DR5, cleaved-caspase3, and BAX proteins expression and downregulated FLIP protein expression. Moreover, quantitative polymerase chain reaction showed that gefitinib modulated the expression of targets related to rmhTRAIL activity.CONCLUSION:These results indicate that epidermal growth factor receptor inhibitors enhance rmhTRAIL antitumor activity in the gefitinib-responsive PC9 cell line, and upregulated DR5 expression plays a critical role in activating caspase-signaling apoptotic pathway.

Expressions of DR5,caspase-8,caspase-9 and caspase-3 in HepG2 Cell Line Treated with Gemcitabine

Gemcitabine inhibits cell growth and induces apoptosis of osteosarcoma cell line MG-63

Apoptosis of Implanted Tumor of Human Primary Gastric Cancer Cells in Nude Mice Induced by Resveratrol

Effect of Gemcitabine on Proliferation, Apoptosis and Polo-Like Kinase-1 Expression of Pancreatic Cancer Cell Line AsPC-1

The Cytotoxic Effect,cell Cycle Perturbations and Apoptosis by Gemcitabine in Human Bladder Cancer Lines

The Apoptotic Pathway of Laryngeal Squamous Carcinoma Cell Line Induced by Combined TRAIL with Chemotherapeutic Drugs or Radiotherapy

Gene Microarrays in Detecting Molecular Mechanisms of Gemcitabine-Mediated Apoptosis on Human Pancr- Eatic Carcinoma Cells Panc-1

The effect of Gemcitabine on pancreatic cancer PC-2 cells growth and gene expression

The effects of Gemcitabine in human non-small cell lung cancer A549 and H1299 cells proliferation and apoptosis

Expression of XIAP in Pancreatic Carcinoma Cell Line BxPC-3 Induced by Gemcitabine

Effect of RGD-conjugated Gemcitabine-Loaded Albumin Nanoparticles on Cell Cycle and Apoptosis of Pancreatic Cancer Cells

Survivin is Involved in Drug Resistance of Pancreatic Cancer PaTu8988 Cells to Gemcitabine

[Synergistic Effects and Mechanisms of Combined Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Chemotherapeutic Drugs or Radiotherapy in Killing Laryngeal Squamous Carcinoma Cells in Vitro].

The Cytoprotective Role Of Gemcitabine-Induced Autophagy Associated With Apoptosis Inhibition In Triple-Negative Mda-Mb-231 Breast Cancer Cells

Gefitinib Upregulates Death Receptor 5 Expression to Mediate Rmhtrail-Induced Apoptosis in Gefitinib-sensitive NSCLC Cell Line.

Overexpression of PlK-1 gene effects of PlK-1 gene on the chemotherapeutic sensitivity of pancreatic carcinoma cell line AsPC-1 response to gemcitabine

The effect of fibronectin and arginine-glycine-aspartic-serine tetrepeptide on chemotherapy sensitivity of liver carcinoma cell lines

Expression of Survivin in Endometrial Cancer and Its Role in Regulating Apoptosis of Endometrial Cancer Cells

Effect of Gemzar Combined with Electron Ray on Tumor Apoptosis in Nude Mice Xenograft of Human Pancreatic Carcinoma

Study of the survivin expression in pancreatic carcinoma cell line PANC-1 induced by gemcitabine

Effect of Autophagy on Gemcitabine-induced A549 Lung Cancer Cell Death and Relevant Mechanisms